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Abstract 
Background 
We aimed to identify interventions documented by randomized controlled trials (RCTs) that reduce 
mortality in adult critically ill and perioperative patients, followed by a survey of clinicians’ opinion 
and routine practice to understand the clinicians’ response to such evidence.  
Methods 
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We performed a comprehensive literature review to identify all topics reported to reduce mortality 
in perioperative and critical care settings according to at least 2 RCTs or to a multicenter RCT or to 
a single center RCT plus guidelines. We generated position statements that were voted online by 
physicians worldwide for agreement, use, and willingness to include in international guidelines. 
Results 
From 262 RCTs manuscripts reporting mortality differences in the perioperative and critically ill 
settings, we selected 27 drugs/techniques/strategies (66 RCTs, most frequently published by NEJM 
-13 papers-, Lancet -7- and JAMA -5-) with an agreement >67% from over 250 physicians (46 
countries). Non-invasive ventilation was the intervention supported by the largest number of RCTs 
(n=13). The concordance between agreement and use (a positive answer both to “do you agree” and 
“do you use”) showed differences between western and other countries and between 
anesthesiologists and ICU physicians.  
Conclusions 
We identified 27 clinical interventions with randomized evidence of survival benefit and strong 
clinician support in support of their potential life-saving properties in perioperative and critically ill 
patients with non-invasive ventilation having the highest level of support. However, clinician views 
appear affected by specialty and geographical location. 
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Introduction 
The perioperative care and intensive care unit (ICU) are settings with a high mortality risk
1
, and this 
has led to the performance of several studies with the aim to improve outcomes. High quality 
scientific clinical research, however, is more difficult to perform in this specific hospital setting, 
due to practical issues (for example randomization in emergent situations) and ethical issues (for 
example, lack of patient's informed consent to be included in the study). Multicenter randomized 
controlled trials (mRCTs) are, therefore, limited in number, with only a few published mRCTs large 
enough to provide significant information on survival. International guidelines and 
recommendations exist, but do not cover all the variables encountered by clinicians in clinical 
practice. Thus, many studies are single-center RCTs (sRCTs), which are easier to perform, but 
contain many sources of bias
2
 affecting the quality of subsequent guidelines. In recent years, 
democracy-based medicine (DBM)
3 
has gained popularity, as this tool allows every physician to 
agree or not with published evidence based medicine (EBM) findings and to state their routine 
practice on the identified issue. 
Our group has previously performed a review of all the mRCTs showing mortality reduction in 
critically ill patients
4
. This analysis gathered all multicenter randomized evidence about critically ill 
patients and focused on mortality. However, the information contained in sRCT was not considered. 
Interestingly, this analysis found that several treatments of respiratory and/or cardiac dysfunction, 
including non-invasive ventilation and mild hypothermia for cardiac arrest, might reduce mortality 
of critically ill patients. Therefore, the identification of factors associated with reduced mortality in 
critically ill patients may also be important for cardio-thoraco-vascular anesthesiologists and 
intensive care specialists, as all such patients present impaired cardiovascular and/or respiratory 
reserve. 
In an effort to perform a more comprehensive evaluation of all the elements influencing mortality in 
critically ill patients, we now performed an updated DBM consensus conference on mortality 
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reduction in critically ill patients taking into account all existing published randomized evidence. 
 
Methods 
MEDLINE/PubMed, Scopus, and Embase were searched by six investigators to identify all 
randomized controlled trials (RCTs) concerning every kind of nonsurgical interventions influencing 
mortality in critically ill and perioperative patients, without publication time limits. The full 
MEDLINE/PubMed search strategy is available in the Supplemental Materials.   
Selected articles had to satisfy all the following criteria: 1) be published in a peer-reviewed journal; 
2) be designed as RCT; 3) relate with nonsurgical interventions (drug/technique/strategy); 4) 
involve the perioperative period or critically ill patients; 5) show a statistically significant reduction 
in mortality. 
We considered patients as critically ill when presenting an acute failure of at least one organ and/or 
need for intensive care and/or emergency treatment, regardless of where they were treated. The 
perioperative period was defined from patient hospital admission before surgery to patient discharge 
after the operation.  
Difference in mortality was considered statistically significant when present at a specific time point 
(landmark mortality) with simple statistical tests and without adjustment for baseline characteristics. 
Trials demonstrating a statistically significant reduction/increase in mortality in only a subgroup of 
patients were included, but this limitation was highlighted in the data collection form.  
Papers were excluded in case one of these criteria was identified at any time of the Consensus 
process: 1) not strictly randomized design (quasi randomized or similar); 2) mortality significance 
found only after statistical adjustments; 3) a trend toward reduction/increase in mortality was 
identified without reaching the p<0.05 level of significance; 4) classification as surgical procedure.  
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For each topic two experts, a rapporteur and a discussant, were selected among the attendees. They 
received the selected papers in advance and were asked to meticulously review the literature, in 
order to find other RCTs not yet identified. A brief presentation, which included a final statement, 
was prepared by the experts. They divided each topic into subtopics if necessary. 
The Consensus meeting was held on the 25
th
 of November 2016 at the Vita Salute University of 
Milan (Italy). The inclusion or exclusion of each topic was suggested by the experts and, in case of 
disagreement among participants, the inclusion of the paper was decided by a vote.  
Topics with a mRCT or with at least two sRCTs or with only one sRCT but supported by guidelines 
were selected. These were included in the Consensus process as “full inclusion” and a statement 
was approved by the participants in person and underwent further steps. 
Up to May 2018, through an interactive web questionnaire 
(http://www.democracybasedmedicine.org), clinicians worldwide had the opportunity to vote in 
support/against the resulting statements. The related articles were all freely downloadable through a 
link on the website. All participants were asked to disclose all potential conflicts of interest. There 
was no sponsor or industry support for this consensus conference. 
For statements with evidence of mortality reduction the following questions were asked: 
1) Do you agree with the below sentence? 2)  Do you routinely use this intervention in your clinical 
practice? 3) Would you include this intervention into future international guidelines to reduce 
perioperative/critically ill patient mortality? 
For each question, the authors included three possible answers: yes/no/“don’t know or does not 
apply”. The authors intentionally did not include the possibility to “partially agree” with a 
statement.  
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After the web vote, the interventions that reached < 67% of agreement were considered as “major 
exclusions”. This lower limit of agreement was chosen because two-thirds of voters represent a 
“qualified majority” in many political or administrative proceedings. This choice is similar to 
previous “democracy-based” consensus conferences the authors have conducted in other clinical 
settings
5,6
. 
 
Analysis before the web vote 
For all “fully included” studies these variables were recorded and analyzed: 1) the intervention and 
its comparator; 2) the setting of the trial; 3) the sample size; 4) the presence of blinding; and 5) the 
duration of follow-up.  
Descriptive statistics were used to examine study variables. Value are expressed as frequency and 
percentage. The difference between two groups was calculated with the Mann-Whitney U test, and 
when more than two groups were involved, Kruskal-Wallis test was used. Statistical significance 
was assumed for p value less than 0.05. 
 
Analysis after the web vote 
The answers from the web survey were analyzed. Double votes were prevented by using the e-mail 
field as the unique identifier. Analyses included only answers without conflict of interests. The 
results of the web vote are expressed as percentage of positive votes. Null votes were excluded. The 
percentage of agreement with selected literature, the use/avoidance in clinical practice and the 
desire to include the intervention in future guidelines were reported. The responders’ specialty was 
considered, to assess whether the management differed among anesthesiologists and intensivists. 
Further analysis relating to responders’ countries were performed to assess whether clinicians’ 
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origin influenced their approach to interventions. For simplification purposes, all countries were 
divided in 2 groups: western countries and others. The gap between agreement and practice use was 
also calculated using the ratio between all the answers with concordance and the total number of 
queries with an answer in both fields (“do you agree” and “do you use/avoid”). The chi-square test 
was used to evaluate differences in percentages among countries. Statistical significance was set at 
p <= 0.05 for all analyses. Statistical analysis was performed using STATA 15 software (StataCorp, 
College Station, TX). 
 
Results 
We identified all RCTs ever performed in critically ill patients and the perioperative setting 
reporting a statistically significant reduction in mortality. The complete list of the 262 identified 
manuscripts is reported in Supplemental Materials (Table s2) with their subsequent selection shown 
in the flow chart (Figure 1) and detailed in the Supplemental Materials (Table s1, s4, s5, s6). 
The final list of 27 interventions and 66 manuscripts
7-72 
which reached consensus after the web vote 
is presented in table 1 and in supplemental materials (table s3) together with the relative percentage 
of agreement, use and willingness to include in future guidelines. Non-invasive ventilation was the 
intervention supported by the largest number of RCTs (n=13) followed by decontamination of the 
digestive tract (n=5). Nine further topics did not reach the pre-specified 67% agreement among the 
web voters and are reported in table 2 as major exclusions.  
The Journals that more frequently published the 66 selected manuscripts were NEJM (13 papers), 
Lancet (7) and JAMA (5). Overall, 251 physicians from 46 countries (Figure 2) participated in the 
web survey. Physicians were divided into three groups: anesthesiologists (n=149), intensive care 
physicians (n=90) and others (n=12).  
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The concordance between agreement and use (a positive answer both to “do you agree” and “do you 
use”) is reported in table 3. There was a statistically significant difference between western and 
other countries for non-invasive ventilation (NIV) in chronic obstructive pulmonary disease 
(COPD), tranexamic acid and high flow nasal cannula (HFNC) (Figure s1). Also between 
anesthesiologists and ICU physicians the difference was significant for early tracheostomy, NIV in 
respiratory failure, early thrombolysis, and volatile anesthetics in cardiac surgery (Figure s2).  
 
Discussion 
Key Findings 
We identified all nonsurgical interventions (drugs, techniques, or strategies) with randomized 
evidence (at least 1 mRCT or 2 sRCTs or 1sRCT supported by guidelines) of a mortality reduction 
in the setting of adult perioperative or critical care medicine. A web vote among more than 250 
physicians from over 40 countries selected the 66 manuscripts (27 interventions) with an agreement 
of >67% and showed a variable degree of agreement for clinical use and intention to include in 
future guidelines of such interventions.  
NIV was the most extensively studied and documented intervention to reduce mortality in critically 
ill patients, with 13 manuscripts grouped into 3 different settings (COPD exacerbation, acute 
respiratory failure and weaning after extubation). The highest degree of agreement (99%) was 
observed for early defibrillation in out of hospital cardiac arrest, but ventilation topics were also 
extremely popular: 99% of agreement for NIV in COPD; 90% for NIV in respiratory failure; 97% 
for protective ventilation and 96% for prone positioning in severe acute respiratory distress 
syndrome (ARDS). 
The percentage of clinical use was always less than agreement. This implies that costs and logistics 
have a role in the widespread application of numerous potentially life-saving interventions or that, 
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as previously suggested
6
, there is a gap between medical literature and clinical practice, possibly 
due to the complexity and heterogeneity of the involved settings.  
We also identified differences between western and other countries, suggesting that some 
interventions are not widespread or not available everywhere. For example, NIV and HFNC had 
overall high percentage of agreement, but lower concordance between agreement and use in non-
western countries. This can be explained only in part by lack of personnel and resources, since 
tranexamic acid, a cheap drug nowadays included in many guidelines (obstetric hemorrhage, 
massive trauma bleeding), is significantly less used in non-western countries.  
 
Relationship to Previous Literature 
Our results could be compared with previous consensus processes conducted by the same authors to 
identify the interventions that can affect mortality in the perioperative period and in critically ill 
patients
4-6
. 
Most of the interventions already discussed in previous consensus processes are growing both in 
terms of agreement and concordance between agreement and use, suggesting that such evidence is 
consolidating over time. Exceptions are represented by volatile anesthetics, selective 
decontamination of the digestive tract and leukocyte depleted blood transfusions, which are losing 
support.  
Several interventions were not reported in previous consensus processes mainly because only 
supported by non-multicentre studies, supported by recent RTCs, because of upgrading of the 
current process. They include thrombolysis after acute myocardial infarction/pulmonary embolism 
(AMI/PE), clopidogrel after AMI, epinephrine in cardiac arrest, amiodarone in cardiac arrest, 
restrictive inspiratory fraction, underfeeding post-refeeding syndrome, early tracheostomy, goal 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
directed therapy, HFNC, procalcitonin-guided antibiotics discontinuation, mechanical chest 
compression devices, vasopressin in cardiac arrest, antithrombin III, and hydrocortisone in sepsis.  
Four interventions (hypothermia, intra-aortic balloon pump, remote ischemic preconditioning and 
locoregional anesthesia) were included in previous consensus conferences but not in the present 
final short list of 27 included topics because new RCTs had evidence against their use or showed 
futility.  
Notably we had two interventions with “conflicting evidence” (at least one RCT showing mortality 
decrease and one RCT showing mortality decrease). Insulin (4 RCTs) and colloids (2 RCTs) were 
very debated during the meeting without reaching consensus.  
 
Implications for Clinical Practice 
Anesthesiologists and ICU physicians treating surgical and critically ill patients make everyday 
decisions on which anesthetic techniques to apply, drugs to administer (or avoid), and other 
nonsurgical strategies to use, often without knowing whether those decisions actually affect survival 
in their patients. Guidelines can provide useful information, but often do not focus on survival and 
describe the effect of drugs, techniques and interventions on intermediate outcomes. Through this 
consensus methodology, all interventions for which there was sufficient, non-conflicting, and 
widely agreed-upon evidence of an impact on perioperative and critically ill adult patients mortality 
were identified. Moreover, these results reflect real-world scenarios on a global scale. 
Our findings emphasize once again, that the evidence of EBM is often not conclusive, not well 
defined and sometimes even antithetical. From this perspective, EBM appears to have, in itself, 
some intrinsic limitations. Therefore, in the “real word”, EBM cannot be the only resource for 
clinicians in their daily decision-making. The democracy-based consensus process, grouping 
together the opinions of hundreds of clinicians from all over the world, can integrate the other 
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“tools” (e.g., guidelines, expert opinions, systematic reviews, surveys) and contribute to giving a 
critical assessment of the available literature by combining the best research evidence with clinical 
expertise. This “fusion” maybe a useful strategy to assess the interaction between evidence and 
practice. 
 
Strengths and Limitations 
We acknowledge that our study presents several limitations. First of all, most of the trials performed 
in the critical care or high-risk perioperative setting are relative small studies since investigators 
might have difficulties to enroll a large number of patients in these clinical contexts. To attenuate 
the risk of including randomized studies at high risk of type I error (such as small single center 
studies) the authors decided to include in the final statements only interventions demonstrated by at 
least 2 RCTs or a mRCT or by a single RCT supported by guidelines. We acknowledge that some 
interventions (e.g. echocardiography, extracorporeal membrane oxygenation) have dramatically 
changed the way we daily manage our patients but have never been validated in RCTs with 
mortality outcomes, so we could not include them in this consensus process. 
The main strength of this study, however, was the combination of EBM with the DBM, which 
allowed the authors to really understand the current opinion and therapeutic approaches of 
clinicians worldwide. 
 
Conclusions 
We performed a systematic review of all the randomized literature with mortality differences in the 
perioperative and critically ill settings (262 manuscripts) and we then selected those interventions 
supported by at least 2 RCTs or a mRCT or by a single RCT plus guidelines. We then surveyed 
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more than 250 clinicians from 46 countries and further selected 66 manuscripts dealing with 27 
interventions with a high percentage of agreement on use and of willingness to include in future 
guideline. We found that despite overall agreement there were differences in perception and self-
reported use between anesthesiologist’s and clinicians form western vs. non-western countries. Our 
findings highlight the complex interaction between evidence, training, culture, resources and 
geography and suggest the need to investigate the impact of affordable interventions in different 
settings. 
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Figure Legends: 
 
Figure 1: Flow chart of the Consensus process. For details see Supplemental. 
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Figure 2: Web Vote countries 
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Table 1: List of the 27 topics which reached an agreement of >67% in the final web vote together with in 
order of percentage of agreement (“do you agree with the statement?” and with percentage of reported 
use (“do you routinely use these interventions in your clinical practice?”) and with willingness to have these 
topics included in future guidelines (“would you include these interventions into future international 
guidelines to reduce perioperative mortality?”). 
STATEMENT AGREEMENT USE GUIDELINES 
Early defibrillation by trained rescuers reduces hospital mortality in 
out of hospital cardiac arrest 
99% 94% 100% 
Non-invasive ventilation reduces mortality in patients with chronic 
obstructive pulmonary disease 
99% 96% 98% 
Protective ventilation with low tidal volumes (6 ml/kg) reduces 
mortality 
97% 97% 97% 
Early thrombolytic therapy in acute myocardial infarction and 
pulmonary embolism reduces mortality 
96% 85% 94% 
Prone positioning reduces mortality in early severe acute respiratory 
distress syndrome patients (P/F< 150) especially if it is used early and 
in relatively long sessions (17-18 hours) 
96% 79% 94% 
Tranexamic acid in traumatic bleeding patients reduces 28-day 
mortality 
95% 86% 92% 
Clopidogrel reduces mortality after acute myocardial infarction 93% 87% 90% 
Avoidance of deep sedation reduces mortality 93% 90% 94% 
Non-invasive ventilation reduces mortality in acute respiratory failure 
in patients with pulmonary edema and/or hypoxemic-hypercapnic 
respiratory failure 
90% 89% 92% 
Albumin reduces mortality in patients with cirrhosis and spontaneous 
bacterial peritonitis 
88% 82% 88% 
Non-invasive ventilation reduces mortality during the weaning after 
extubation 
86% 81% 88% 
Epinephrine reduces mortality in cardiac arrest 84% 94% 92% 
Amiodarone reduces mortality to hospital admission in out-of-hospital 
cardiopulmonary resuscitation 
83% 71% 81% 
Restrictive inspiratory oxygen fraction reduces mortality in intensive 
care unit patients and in the perioperative setting 
83% 70% 70% 
Underfeeding reduces mortality in patients with refeeding syndrome 82% 68% 82% 
Volatile anaesthetics reduce mortality in cardiac surgery 81% 78% 78% 
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Early tracheostomy in severe stroke and early percutaneous 
tracheotomy in medical patients requiring prolonged ventilation (>14 
days) reduce mortality 
80% 75% 79% 
Leukocyte-depleted blood transfusions reduce mortality in cardiac 
surgery 
79% 59% 79% 
Goal directed therapy reduces hospital mortality in patients with 
septic shock 
77% 76% 79% 
High flow nasal cannulae reduces mortality in patients with acute 
respiratory failure 
77% 61% 75% 
Procalcitonin-guided antibiotic discontinuation reduces mortality of 
critically ill patients 
76% 61% 75% 
Mechanical chest compression devices reduce short term mortality in 
cardiac arrest 
75% 50% 75% 
Selective decontamination of the digestive tract reduces mortality of 
critically ill patients 
74% 32% 66% 
Vasopressin with or without steroids reduces mortality cardiac arrest 
patients 
70% 34% 65% 
Levosimendan reduces mortality in patients with cardiogenic shock 
and low cardiac output syndrome 
70% 57% 66% 
Antithrombin III reduces mortality in septic and burn injured patients 67% 33% 62% 
Hydrocortisone reduces mortality in septic shock 67% 66% 70% 
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Table 2: Major Exclusions after the Web Vote. These topics did not reach 67% of agreement. Here are listed as Pubmed 
identification number (PM ID), journal of publication, first author, year of publication, relative statement approved during the 
meeting and percentage of agreement after the web vote. 
 
  
PM ID JOURNAL FIRST 
YE
AR 
STATEMENT 
AGREE
MENT 
15333
422 
Anesth. Analg 
Crimi et 
al. 
20
04 
Vitamin C reduces mortality in ICU patients 59% 
27162
802 
J Res Pharm Pract. 
Zabet et 
al. 
20
16 
15557
131 
Am. J. Respir. Crit. 
Care Med. 
Confalo
nieri et 
al. 
20
04 
Hydrocortisone reduces mortality in community acquired pneumonia 54% 
11574
732 
Blood Purif. 
Nemoto 
et al. 
20
01 
Polymyxin B fibers reduce mortality 
 
12495
686 
J. Hosp. Infect 
Nakamu
ra et al. 
20
03 
52% 
19531
784 
JAMA 
Cruz et 
al. 
20
09 
 
24108
526 
JAMA 
Morelli 
et al. 
20
13 
Esmolol reduces mortality in patients with septic shock 
 
26955
704 
Zhonghua Yi Shi Za 
Zhi 
Xinqiang 
et al. 
20
15 
51% 
26387
030 
Clin Drug Investig 
Wang et 
al. 
20
15 
 
19934
423 
JAMA 
Olasvee
ngen et 
al. 
20
09 
Atropine reduces mortality to hospital admission in out of hospital cardiac 
arrest 
49% 
17804
841 
N. Engl. J. Med. 
Corwin 
et al. 
20
07 Erythropoietin reduces mortality in critically ill (including trauma) patients, 
especially those with APACHE score <20 
47% 
12472
324 
JAMA 
Corwin 
et al. 
20
02 
25586
270 
Acta Orthop 
Gregers
en et al. 
20
15 
A liberal red blood cell transfusion strategy reduces mortality in cardiac 
and non cardiac surgery 
36% 
25401
417 
Anesthesiology 
de 
Almeida 
et al. 
20
15 
25760
354 
N. Engl. J. Med. 
Sloan et 
al. 
20
15 
17095
947 
Crit. Care Med. 
Angstwu
rm et al. 
20
07 
Selenium reduces mortality in patients with sepsis 33% 
33075
70 
Am. Rev. Respir. 
Dis. 
Eisenber
g et al. 
19
87 
The use of pulmonary artery catheter reduces mortality in critically ill 
patients 
27% 
19296
10 
Ann. Surg. 
Berlauk 
et al. 
19
91 
31917
58 
Chest 
Shoema
keret al. 
19
88 
20926
981 
Shock Yu et al. 
20
11 
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Table 3: Concordance between agreement and use for all topics reaching > 67% of agreement after the Web Vote. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
AMI: acute myocardial injury; ARDS: acute respiratory distress syndrome; ARF: acute respiratory failure; CPR: cardiopulmonary 
resuscitation; COPD: chronic obstructive pulmonary disease; FiO2: inspiratory oxygen fraction; NIV: non-invasive ventilation; PE: 
pulmonary embolism 
 
 
 
TOPIC 
CONCORDANCE 
agreement/self-reported actual use 
% 
Protective ventilation 98 
NIV in COPD 97 
NIV in pulmonary edema and hypoxemic/hypercapnic RF 93 
Early defibrillation 93 
Avoidance of deep sedation 93 
Goal directed therapy in septic shock 93 
Clopidogrel AMI 91 
Tranexamic acid in traumatic bleeding 90 
NIV after extubation 89 
Early tracheostomy 88 
Underfeeding post refeeding syndrome 88 
Albumin in cirrhosis 88 
Early thrombolysis in AMI/PE 87 
Restrictive FiO2 87 
Epinephrine in cardiac arrest 87 
Volatile anesthetics in cardiac surgery 84 
Prone positioning in severe ARDS 83 
Amiodarone CPR 82 
Hydrocortisone in septic shock 81 
Levosimendan cardiogenic shock 80 
Procalcitonin guided antibiotics 80 
Leucocyte deplete blood in cardiac surgery 79 
Mechanical chest compression 76 
High flow nasal cannulae in ARF 75 
Antithrombin III in septic and burned 74 
Vasopressin in cardiac arrest 70 
Selective decontamination 62 
